Causal relationships between coffee intake, apolipoprotein B and gastric, colorectal, and esophageal cancers: univariable and multivariable Mendelian randomization

• Published in: European journal of nutrition 2024-03, Vol.63 (2), p.469-483
• Main Authors: Liu, Xingwu, Yu, Han, Yan, Guanyu, Xu, Boyang, Sun, Mingjun, Feng, Mingliang
• Format: Article
• Language: English
• Subjects: Apolipoprotein B; Apolipoproteins; Apolipoproteins B; Biobanks; Body mass index; Chemistry; Chemistry and Materials Science; Coffee; Coffee - adverse effects; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - epidemiology; Colorectal Neoplasms - genetics; Esophageal cancer; Esophageal Neoplasms - epidemiology; Esophageal Neoplasms - genetics; Esophagus; Gastric cancer; Humans; Mendelian Randomization Analysis; Nutrition; Original Contribution; Pleiotropy; Statistical analysis; Stomach Neoplasms - epidemiology; Stomach Neoplasms - genetics
• ISSN: 1436-6207; 1436-6215
• DOI: 10.1007/s00394-023-03281-y

Purpose Coffee intake and apolipoprotein B levels have been linked to gastric, colorectal, and esophageal cancers in numerous recent studies. However, whether these associations are all causal remains unestablished. This study aimed to assess the potential causal associations of apolipoprotein B and coffee intake with the risk of gastric, colorectal, and esophageal cancers using Mendelian randomization analysis. Methods In this study, we utilized a two-sample Mendelian randomization analysis to access the causal effects of coffee intake and apolipoprotein B on gastric, colorectal, and esophageal cancers. The summary statistics of coffee intake ( n  = 428,860) and apolipoprotein B ( n  = 439,214) were obtained from the UK Biobank. In addition, the summary statistics of gastric cancer, colorectal cancer, and esophageal cancer were obtained from the FinnGen biobank ( n  = 218,792). Inverse variance weighted, MR–Egger, weighted median, and weighted mode were applied to examine the causal relationship between coffee intake, apolipoprotein B and gastric, colorectal, and esophageal cancers. MR–Egger intercept test, Cochran’s Q test, and leave-one-out analysis were performed to evaluate possible heterogeneity and pleiotropy. Steiger filtering and bidirectional mendelian randomization analysis were performed to evaluate the possible reverse causality. Results The result of the inverse variance weighted method indicated that apolipoprotein B levels were significantly associated with a higher risk of gastric cancer (OR = 1.392, 95% CI 1.027–1.889, P  = 0.0333) and colorectal cancer (OR = 1.188, 95% CI 1.001–1.411, P  = 0.0491). Furthermore, multivariable Mendelian randomization analysis also revealed a positive association between apolipoprotein B levels and colorectal cancer risk, but the effect of apolipoprotein B on gastric cancer risk disappeared after adjustment of coffee intake, body mass index or lipid-related traits. However, we did not discover any conclusive evidence linking coffee intake to gastric, colorectal, or esophageal cancers. Conclusions This study suggested a causal association between genetically increased apolipoprotein B levels and higher risk of colorectal cancer. No causal relationship was observed between coffee intake and gastric, colorectal, or esophageal cancers.